Why should pharma invest in digital products for those living with rare diseases?
pharmaphorum
NOVEMBER 23, 2022
Research in rare diseases will benefit from identifying cause and effect, which consider behaviours, social economics, and the patient’s emotional state. This new information can help pharma increase adherence by improving the quality of treatment and creating patient-centred programs and materials.
109 
Let's personalize your content